Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07154251 · ClinicalTrials.gov registry record · NA

Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery

A NA study of Type 1 Diabetes (T1D), sponsored by University Hospitals Cleveland Medical Center.

Recruiting
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT07154251: Recruiting NA study of Type 1 Diabetes (T1D), sponsored by University Hospitals Cleveland Medical Center.

NCT07154251 is a NA study of Type 1 Diabetes (T1D) that is actively recruiting participants, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 16 participants, below the 180-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07154251, a NA study of Type 1 Diabetes (T1D), is actively recruiting participants, sponsored by University Hospitals Cleveland Medical Center.

RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

This study uses community health workers (CHW) as diabetes technology coaches for African American children using automated insulin delivery systems but have an HbA1c of 8% or higher. Families will meet with the CHW monthly x 6 months with additional visits as needed. All participants and parents/guardians will fill out questionnaires at the beginning and end of the 6 month intervention in addition to an interview at 6 months. This will be followed by 6 months with no extra help from the CHW, but we will continue to follow CGM and pump download data.

Conditions Studied

Interventions

  • OTHER Community Health Worker

Study Locations (1)

Ohio

  • University Hospitals Cleveland Medical Center - Cleveland

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2025-11-06
Est. Completion 2027-03-01
Phase NA

What NCT07154251 shows while recruiting

NCT07154251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 180-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (91% lower).

The record links to 1 condition, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Community Health Worker is the first listed.

NCT07154251 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT07154251 about?

NCT07154251 is a clinical study titled "Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery". This study uses community health workers (CHW) as diabetes technology coaches for African American children using automated insulin delivery systems but have an HbA1c of 8% or higher. Families will meet with the CHW monthly x 6 months with additional visits as needed. All participants and parents/gu...

What is the current status of trial NCT07154251?

This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-11-06. Estimated completion is 2027-03-01.

What conditions does trial NCT07154251 study?

This clinical trial studies the following conditions: Type 1 Diabetes (T1D).

What interventions are being tested in trial NCT07154251?

The interventions under investigation include: Community Health Worker (OTHER).

Who is sponsoring clinical trial NCT07154251?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07154251 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes (T1D)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07154251's enrollment target sits among peer trials

16 15th of 17 higher than 2 of 17 other Type 1 Diabetes (T1D) trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 1 Diabetes (T1D) trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07154251, the US trial registry maintained by the National Library of Medicine. NCT07154251 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.